G

Global Health Ltd
NSE:MEDANTA

Watchlist Manager
Global Health Ltd
NSE:MEDANTA
Watchlist
Price: 1 096.5 INR -0.11% Market Closed
Market Cap: 294.5B INR
Have any thoughts about
Global Health Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one MEDANTA stock under the Base Case scenario is 1 250.88 INR. Compared to the current market price of 1 096.5 INR, Global Health Ltd is Undervalued by 12%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MEDANTA Relative Value
Base Case
1 250.88 INR
Undervaluation 12%
Relative Value
Price
G
Worst Case
Base Case
Best Case

Valuation Multiples

8.5
P/S
P/S
Price to Sales
8.5
vs History
38
vs Industry
14
Median 3Y
7.7
Median 5Y
7.7
Industry
2.3
Forward
7.9
More Details
60.3
P/E
P/E
Price to Earnings
60.3
vs History
38
vs Industry
6
Median 3Y
56.3
Median 5Y
56.3
Industry
23.1
Forward
55.2
More Details
46.8
P/OCF
P/OCF
Price to OCF
46.8
vs History
26
vs Industry
6
Median 3Y
32.4
Median 5Y
32.4
Industry
14.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
4
Median 3Y
-356.1
Median 5Y
-356.1
Industry
20.1
More Details
10.1
P/B
P/B
Price to Book Value
10.1
vs History
34
vs Industry
5
Median 3Y
9.3
Median 5Y
9.3
Industry
2.2
More Details
8.3
EV/S
EV/S
Enterprise Value to Sales
8.3
vs History
38
vs Industry
13
Median 3Y
7.6
Median 5Y
7.6
Industry
2.4
Forward
7.8
More Details
10.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.9
vs History
38
vs Industry
16
Median 3Y
10
Median 5Y
10
Industry
5
More Details
34.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
34.7
vs History
38
vs Industry
7
Median 3Y
34.1
Median 5Y
34.1
Industry
12.7
Forward
31.9
More Details
44.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
44.7
vs History
38
vs Industry
7
Median 3Y
40.8
Median 5Y
40.8
Industry
17.1
Forward
41.3
More Details
46.1
EV/OCF
EV/OCF
Enterprise Value to OCF
46.1
vs History
26
vs Industry
7
Median 3Y
31.9
Median 5Y
31.9
Industry
14
More Details
437.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
437.1
vs History
3
vs Industry
5
Median 3Y
51.9
Median 5Y
51.9
Industry
18
More Details
9.5
EV/IC
EV/IC
Enterprise Value to IC
9.5
vs History
34
vs Industry
7
Median 3Y
8.7
Median 5Y
8.7
Industry
1.9
More Details

Multiples Across Competitors

MEDANTA Competitors Multiples
Global Health Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Global Health Ltd
NSE:MEDANTA
294.4B INR 8.5 60.3 34.7 44.7
US
HCA Healthcare Inc
NYSE:HCA
78.6B USD 1.1 13.3 8.3 10.9
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 9.3 44 39 45.3
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
24.1B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
20B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
129.6B CNY 6.3 35.7 26.9 26.9
MY
IHH Healthcare Bhd
KLSE:IHH
62.4B MYR 2.7 23.5 12.7 18.4
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1.1T INR 19.5 105.1 72.9 86.9
US
Tenet Healthcare Corp
NYSE:THC
12.3B USD 0.6 3.9 5.2 6.6
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
1T INR 5.3 100.4 41.8 57.3
US
Universal Health Services Inc
NYSE:UHS
12B USD 0.8 11.7 7.8 10.7

See Also

Summary
MEDANTA intrinsic value, competitors valuation, and company profile.
DCF Valuation
MEDANTA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MEDANTA stock valuation using valuation multiples.
Wall Street Estimates
MEDANTA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MEDANTA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.